Abstract
Despite brucellosis having a low incidence rate in developed nations, it still remains the leading zoonotic disease in the world. Culturing of Brucella spp. provides good specificity but in cases where the fever is intermittent, sensitivity is problematic. This has led to the development of serological methods of detection. Brucella agglutination methods have been considered the serological gold‐standard since their inception, although commercial Brucella IgG and IgM enzyme‐linked immunosorbentassays are available to potentially aid in the diagnosis of the disease. In our study, anti‐Brucella IgG and IgM assays were compared with agglutination. Individually the IgG assay tested had an accuracy of 56% and the IgM assay had an accuracy of 77%. These poor accuracies reinforce Centers for Disease Control's conclusion that nonagglutination tests should not be used to confirm brucellosis. J. Clin. Lab. Anal. 24:160–162, 2010. © 2010 Wiley‐Liss, Inc.
Keywords: Brucella, serology, agglutination, ELISA
REFERENCES
- 1. Mandell G, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 2004. [Google Scholar]
- 2. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91–99. [DOI] [PubMed] [Google Scholar]
- 3. Mantur BG, Amarnath SK. Brucellosis in India—a review. J Biosci 2008;33:539–547. [DOI] [PubMed] [Google Scholar]
- 4. CDC . Public health consequences of a false‐positive laboratory test result for Brucella—Florida, Georgia, and Michigan, 2005. MMWR Morb Mortal Wkly Rep 2008;57:603–605. [PubMed] [Google Scholar]
- 5. Gomez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008;15:1031–1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Renoux M. A passive hemagglutination test for the detection of Brucella infection. J Immunol Methods 1980;32:349–355. [DOI] [PubMed] [Google Scholar]
- 7. Fleiss JF. Statistical Methods for Rates and Proportions. New York: Wiley; 1981. [Google Scholar]
- 8. Abdoel TH, Smits HL. Rapid latex agglutination test for the serodiagnosis of human brucellosis. Diagn Microbiol Infect Dis 2007;57:123–128. [DOI] [PubMed] [Google Scholar]
- 9. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 1991;13:359–372. [DOI] [PubMed] [Google Scholar]
- 10. Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis 2003;46:241–243. [DOI] [PubMed] [Google Scholar]
- 11. WHO . Joint FAO/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser 1986;740:1–132. [PubMed] [Google Scholar]
- 12. Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007;4:e317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]. BMC Infect Dis 2004;4:18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Al‐Hajjaj MS, Al‐Kassimi FA, Al‐Mobeireek AF, Alzeer AH. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology 2001;6:317–322. [DOI] [PubMed] [Google Scholar]
- 15. Araj GF, Kattar MM, Fattouh LG, Bajakian KO, Kobeissi SA. Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme‐linked immunosorbent assays for diagnosis of human brucellosis. Clin Diagn Lab Immunol 2005;12:1334–1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. CDC . Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997;46:1–55. [PubMed] [Google Scholar]